Streetbeat News

Revenues

TXG

10x Genomics (NASDAQ:TXG) reported Q3 2024 revenue of $151.7 million, missing expectations of $162.245 million. Instrument sales dropped 46%, while consumables and services saw growth. The company experienced regional revenue declines in the Americas but growth in EMEA and APAC. TXG stock fell 26.20% in premarket trading.

Portfolio Pulse from Vandana Singh

October 10, 2024 | 11:36 am

THTX

Theratechnologies has revised its FY2024 sales guidance downward from $87-90 million to $83-85 million, aligning closely with the estimated $84.044 million.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:36 am

YYAI

Connexa Sports Technologies has entered an exclusive license agreement with Guofu Enterprise Management, expecting to generate over $30 million in license income for YYEM by the end of 2026. The agreement includes minimum royalty payments to YYEM.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:34 am

VRTS

Virtus Investment Partners reported preliminary assets under management (AUM) of $183.7 billion and other fee-earning assets of $2.4 billion, totaling $186.1 billion as of September 30, 2024. The increase is due to market performance and positive net flows in retail separate accounts, despite net outflows in institutional accounts and open-end funds.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:20 am

MAIN

Main Street Capital originated or increased commitments in its private loan portfolio by $270.3M and funded total investments of $309.3M in Q3 2024. Notable investments include loans to tech-enabled marketing, industrial equipment services, tourism, and various other sectors.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:13 am

INDV

Indivior has reported preliminary Q3 net revenue between $302 million and $309 million, surpassing the estimated $289.37 million.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:12 am

INDV

Indivior has announced that while the expected peak net revenue for SUBLOCADE remains over $1.5 billion, they no longer anticipate reaching a $1 billion run rate by the end of 2025. The company is seeking efficiencies to support SUBLOCADE's growth and maintain margins.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:08 am

INDV

Indivior has revised its FY24 net revenue outlook downwards due to faster adoption of a competing product, variability in funding timing, and lower trade stocking.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:07 am

NEOG

Neogen has reaffirmed its FY2025 sales guidance, projecting sales between $925 million and $955 million, aligning with market estimates.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:05 am

TFPM

Triple Flag Precious Metals reported a revenue of $73.7 million for Q3 2024, derived from the sale of 29,773 gold equivalent ounces.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 11:04 am